Cargando…

Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity

Diabetes is a metabolic disorder with an increasing global prevalence. Somatostatin (SST), a peptide hormone, regulates hormone secretion via five SST receptor (SSTR) subtypes (SSTR1–5) in a tissue‐specific manner. As SSTR5 is expressed in pancreatic β‐cells and intestinal L‐cells, studies have sugg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamura, Yumiko Okano, Sugama, Jun, Abe, Shin‐ichi, Shimizu, Yuji, Hirose, Hideki, Watanabe, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803904/ https://www.ncbi.nlm.nih.gov/pubmed/36585794 http://dx.doi.org/10.1002/prp2.1043

Ejemplares similares

A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice
por: Yashiro, Hiroaki, et al.
Publicado: (2016)

Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus
por: Hirai, Hiroyuki, et al.
Publicado: (2016)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Vergari, Elisa, et al.
Publicado: (2019)

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease
por: Sugama, Jun, et al.
Publicado: (2020)

Synthesis of somatostatin by breast cancer cells and their inhibition by exogenous somatostatin and sandostatin.
por: Nelson, J., et al.
Publicado: (1989)

Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin
por: Zhou, Guisheng, et al.
Publicado: (2014)

A selective nonpeptide somatostatin receptor 5 agonist effectively decreases insulin secretion in hyperinsulinism
por: Juliana, Christine A., et al.
Publicado: (2023)

Inhibition by Somatostatin Interneurons in Olfactory Cortex
por: Large, Adam M., et al.
Publicado: (2016)

Selective Somatostatin 5 (SST5) and Somatostatin 2 (SST2) Nonpeptide Agonists Potently Suppress Glucose- and Tolbutamide-Stimulated Dynamic Insulin Secretion From Isolated Human Islets
por: Rico, Elizabeth, et al.
Publicado: (2021)

Impact of Oxidative Stress and Peroxisome Proliferator–Activated Receptor γ Coactivator-1α in Hepatic Insulin Resistance
por: Kumashiro, Naoki, et al.
Publicado: (2008)

Endurance Runners with Intramyocellular Lipid Accumulation and High Insulin Sensitivity Have Enhanced Expression of Genes Related to Lipid Metabolism in Muscle
por: Kakehi, Saori, et al.
Publicado: (2020)

Structural insights into ligand recognition and selectivity of somatostatin receptors
por: Zhao, Wenli, et al.
Publicado: (2022)

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
por: Shamsi, Bilal Haider, et al.
Publicado: (2021)

Somatostatin and Somatostatin-Containing Interneurons—From Plasticity to Pathology
por: Liguz-Lecznar, Monika, et al.
Publicado: (2022)

γ-Aminobutyric Acid Transporter 2 Mediates the Hepatic Uptake of Guanidinoacetate, the Creatine Biosynthetic Precursor, in Rats
por: Tachikawa, Masanori, et al.
Publicado: (2012)

Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses
por: Kobayashi, Chisa, et al.
Publicado: (2022)

Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion
por: van der Meulen, Talitha, et al.
Publicado: (2015)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Somatostatin and Somatostatin-Containing Neurons in Shaping Neuronal Activity and Plasticity
por: Liguz-Lecznar, Monika, et al.
Publicado: (2016)

Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4
por: Börzsei, Rita, et al.
Publicado: (2022)

Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression
por: Lu, Yao-Yao, et al.
Publicado: (2018)

Insulin sensitivity and hepatic glucose production in sepsis
por: Zourek, M, et al.
Publicado: (2005)

Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD
por: Tundo, Grazia, et al.
Publicado: (2012)

SAT-169 Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists Suppress Glucose- and Sulfonylurea-Induced Insulin Secretion in Rats
por: Sturchler, Emmanuel, et al.
Publicado: (2019)

Selective inhibition of somatostatin-positive dentate hilar interneurons induces age-related cellular changes and cognitive dysfunction
por: Lyu, Jinrui, et al.
Publicado: (2023)

Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer
por: SHI, XUEFEI, et al.
Publicado: (2013)

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
por: del Olmo-Garcia, Maria Isabel, et al.
Publicado: (2021)

Selective Interactions of Mouse Melanocortin Receptor Accessory Proteins with Somatostatin Receptors
por: Wang, Meng, et al.
Publicado: (2022)

Somatostatin, Olfaction, and Neurodegeneration
por: Saiz-Sanchez, Daniel, et al.
Publicado: (2020)

PSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
por: Ferrara-Cook, Christine, et al.
Publicado: (2022)

Cholecystokinin and Somatostatin Negatively Affect Growth of the Somatostatin-RIN-14B Cells
por: El-Kouhen, Karim, et al.
Publicado: (2009)

Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
por: Klomp, M.J., et al.
Publicado: (2020)

Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity
por: Kubota, Naoto, et al.
Publicado: (2016)

The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
por: Ørgaard, Anne, et al.
Publicado: (2017)

An Exploratory Randomized Trial of SCO-792, an Enteropeptidase Inhibitor, in Patients With Type 2 Diabetes and Albuminuria
por: Kagawa, Tomoya, et al.
Publicado: (2022)

Spirulina platensis and its ingredient biopterin glucoside improved insulin sensitivity in non-alcoholic steatohepatitis model
por: Fujihara, Yuri, et al.
Publicado: (2021)

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_at6ilm8qcined5uub6mcnkl9ij